Verification evidence is still being completed.
PDF / print export
Alligator Bioscience
Lund, Sweden
- Verified lead
- Soren Bregenholt
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Immuno-Oncology, Antibody Therapeutics, CD40 Biology, and Clinical Drug Development
- Review cycle
- May 2026
- Full address
- Alligator Bioscience AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Alligator Bioscience contact page confirming the Lund headquarters address.
- Editorial note
- Alligator Bioscience is published because official company materials confirm current leadership, Lund operating address, and a clear antibody-based oncology platform.
Immuno-Oncology, Antibody Therapeutics, CD40 Biology, and Clinical Drug Development
Official leadership disclosure, Official Lund headquarters disclosure, Clinical-stage antibody platform claim
Alligator Bioscience is published because official company materials confirm current leadership, Lund operating address, and a clear antibody-based oncology platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Lund, Sweden
Alligator Bioscience
Immuno-Oncology, Antibody Therapeutics, CD40 Biology, and Clinical Drug Development · Clinical-stage antibody platform
Alligator Bioscience runs antibody drug development, tumor-directed immunotherapy, and clinical oncology programs in Lund, Sweden.
- Lead
- Soren Bregenholt (verified ↗)
- Address
- Alligator Bioscience AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical-stage antibody platform
- Capabilities
- Antibody Drug Development · Tumor-Directed Immunotherapy · Clinical Oncology Programs
- Founded
- 2001
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Soren Bregenholt
CEO
Full addressAlligator Bioscience AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Alligator Bioscience contact page listing the Lund headquarters address.
Open sourceClinical-stage antibody platform
Lund, Sweden. Immuno-Oncology, Antibody Therapeutics, CD40 Biology, and Clinical Drug Development. Review completed on 21 Mar 2026.
Swedish corporate and clinical-development oversight
Official leadership disclosure, Official Lund headquarters disclosure, Clinical-stage antibody platform claim
Immuno-Oncology, Antibody Therapeutics, CD40 Biology, and Clinical Drug Development
Alligator Bioscience is published because official company materials confirm current leadership, Lund operating address, and a clear antibody-based oncology platform.
Editorial note
Alligator Bioscience is published because official company materials confirm current leadership, Lund operating address, and a clear antibody-based oncology platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Antibody Drug Development
Tumor-Directed Immunotherapy
Clinical Oncology Programs
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Antibody-development workflow
Immunotherapy R&D systems
Clinical program infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Alligator Bioscience located?
- Alligator Bioscience operates from Alligator Bioscience AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, Sweden, Lund, Sweden.
- Who runs Alligator Bioscience?
- Alligator Bioscience is led by Soren Bregenholt, CEO. Verified 21 Mar 2026.
- What does Alligator Bioscience do?
- Alligator Bioscience runs antibody drug development, tumor-directed immunotherapy, and clinical oncology programs in Lund, Sweden. Core capabilities: Antibody Drug Development, Tumor-Directed Immunotherapy, Clinical Oncology Programs.
Editorial context
Related technical briefs
Briefs that name Lund as a covered market or city.